REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPHW and the CUSIP is 76152G118. A total of 15 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,620 | -13.0% | 25,727 | 0.0% | 0.00% | – |
| Q2 2023 | $45,563 | +11.2% | 25,727 | -37.2% | 0.00% | – |
| Q1 2023 | $40,959 | +1.0% | 40,959 | 0.0% | 0.00% | – |
| Q4 2022 | $40,549 | +211.9% | 40,959 | -37.7% | 0.00% | – |
| Q3 2022 | $13,000 | +8.3% | 65,752 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -33.3% | 65,752 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | -21.7% | 65,752 | 0.0% | 0.00% | – |
| Q4 2021 | $23,000 | -11.5% | 65,752 | 0.0% | 0.00% | – |
| Q3 2021 | $26,000 | -21.2% | 65,752 | 0.0% | 0.00% | – |
| Q2 2021 | $33,000 | +22.2% | 65,752 | +11.6% | 0.00% | – |
| Q1 2021 | $27,000 | -32.5% | 58,912 | -0.2% | 0.00% | – |
| Q4 2020 | $40,000 | – | 59,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueCrest Capital Management Ltd | 1,235,000 | $222,000 | 0.01% |
| Arena Investors LP | 85,000 | $15,000 | 0.01% |
| UBS Group AG | 431 | $0 | 0.00% |
| AQR Arbitrage LLC | 55,839 | $10,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Walleye Trading LLC | 65,752 | $12,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 57,064 | $10,000 | 0.00% |
| Walleye Capital LLC | 89,623 | $16,000 | 0.00% |